Author:
Nakamura Takafumi,Peng Kah-Whye,Harvey Mary,Greiner Suzanne,Lorimer Ian A J,James Charles D,Russell Stephen J
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference36 articles.
1. Peng, K.W. et al. Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98, 2002–2007 (2001).
2. Peng, K.-W. et al. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res. 62, 4656–4662 (2002).
3. Grote, D. et al. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97, 3746–3754 (2001).
4. Phuong, L.K. et al. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res. 63, 2462–2469 (2003).
5. Dorig, R.E., Marcil, A., Chopra, A. & Richardson, C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295–305 (1993).
Cited by
229 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献